Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Type 1 Diabetes
Pioneering Diamyd(R) Study to Prevent Childhood Diabetes Approved
March 18th, 2009
Diamyd Medical announces that the Swedish Medical Products Agency has approved a study with the Diamyd(R) diabetes vaccine in children with high risk to develop type 1 diabetes. "To vaccinate children against diabetes has from the outset been one of Diamyd Medical's long term goals," says Elisabeth Lindner, President and CEO of Diamyd Medical. "Type 1 diabetes is a life-long and very serious disease and it is good if we now can prevent it. It would avoid a lot of anxiety, suffering and costs for the children and their families as well as the rest of Society." At Malmo University Hospital in Sweden, large screening tests results in a continuous...
Source: Vaccine Weekly (2009-03-18)
|
